GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orexo AB (OSTO:ORX) » Definitions » Institutional Ownership

Orexo AB (OSTO:ORX) Institutional Ownership : 2.37% (As of Dec. 11, 2024)


View and export this data going back to 2005. Start your Free Trial

What is Orexo AB Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Orexo AB's institutional ownership is 2.37%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Orexo AB's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Orexo AB's Float Percentage Of Total Shares Outstanding is 0.00%.

Orexo AB Institutional Ownership Historical Data

The historical data trend for Orexo AB's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orexo AB Institutional Ownership Chart

Orexo AB Historical Data

The historical data trend for Orexo AB can be seen below:

2024-02-29 2024-03-31 2024-04-30 2024-05-31 2024-06-30 2024-07-31 2024-08-31 2024-09-30 2024-10-31 2024-11-30
Institutional Ownership 2.45 2.31 2.31 2.32 2.36 2.36 2.34 2.35 2.38 2.37

Orexo AB Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Orexo AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orexo AB (OSTO:ORX) » Definitions » Institutional Ownership
Comparable Companies
OSTO:ENZY OSTO:MOB XSAT:DICOT OSTO:ERMA OSTO:NANEXA OSTO:VIVE XSAT:ACUC OSTO:KLAR OSTO:TOL OSTO:NEWBRY ZTS XTER:MRK NSE:SUNPHARMA LSE:HLN TSE:4502 XSWX:GALD XTAE:TEVA XSWX:SDZ NSE:DIVISLAB HKSE:03692
Traded in Other Exchanges
ORXOY:USA ORXOF:USA C5G:Germany
Address
Virdings alle 32 A, P.O. Box 303, Uppsala, SWE, 75105
Website
https://www.orexo.com
Orexo AB has operations in Sweden and the United States. Operations are monitored and presented in the segments USA Pharma, Digital Therapeutics (DTx), and HQ & Pipeline. The majority is from the USA Pharma segment. Geographically, the majority is derived from the United States. USA Pharma includes the commercialization of fully owned pharmaceuticals in the United States market. Digital Therapeutics include the commercialization of Orexo's groundbreaking evidence-based digital therapeutics, mainly in the United States market, which is in an early development stage. HQ &Pipeline includes the Development of pharmaceuticals performed at Orexo's headquarters in Uppsala, Sweden.

Orexo AB Headlines

No Headlines